Author:
Kröz M.,Quittel F.,Reif M.,Zerm R.,Pranga D.,Bartsch C.,Brinkhaus B.,Büssing A.,Gutenbrunner C.,Brink Fadime ten,Berger Bettina,Weninger Annette,Girke Matthias,Müller-Glinz Augustina,Heckmann Christian,
Abstract
AbstractCancer-related fatigue (CRF) is a frequent long-term symptom in non-metastasized breast cancer patients (BC). This 4-year follow-up intended to compare the long-term effects of a 10-week multimodal therapy (MT: sleep education, psychoeducation, eurythmy- and painting therapy) and combination therapy [CT: MT plus aerobic training (AT)] to AT-control. BC-patients were randomized or allocated by preference to three arms in a comprehensive cohort study. Primary outcome was a composite score including Pittsburgh Sleep Quality Index (PSQI) and Cancer Fatigue Scale (CFS-D), captured at baseline, after 10 weeks of intervention (T1), 6 months later (T2), and after 4 years (T3). We exploratively tested for superiority of MT and CT versus AT after 4 years (T3) based on the statistical model of the main analysis. Of 126 (65 randomized) BC-patients included, 105 started treatments and 79 were re-assessed for long-term effects (T3). MT and CT were superior over AT after 4 years regarding PSQI/CFS-D and PSQI sum-score, respectively (all p < 0.05), but not for CFS-D. The multimodal and combination treatment for breast cancer patients with CRF indicates sustainable long-term superiority over aerobic training for the outcomes sleep quality and combined sleep quality/fatigue. A confirmative randomized controlled trial is warranted.
Funder
Mahle Stiftung
Christophorus Stiftung, Germany
Dr. Hauschka Stiftung, Germany
Stiftung Helixor, Germany
Signe ja Ane Gyllenbergin Säätiö
Humanus Institute, Germany
Software AG – Stiftung
Publisher
Springer Science and Business Media LLC
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Supportivtherapien im Vergleich;Onkologische Welt;2023-05
2. Prävention und Therapie;Tumorassoziierte Fatigue;2023